Unstaged cancer: Long-term decline in incidence by site and by demographic and socioeconomic characteristics

Cancer Causes and Control

Volumn 28, Issue 4, 2017, Pages 341-349

  Herget, Kimberly ^a,b   Stroup, Antoinette ^c   Smith, Ken ^a,b   Wen, Ming ^a   Sweeney, Carol ^a,b,d  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Health disparities; Incidence; SEER; Socioeconomic status; Staging

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER OF UNKNOWN PRIMARY SITE; CANCER STAGING; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GLOBAL DISEASE BURDEN; HEALTH DISPARITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RACE DIFFERENCE; SOCIOECONOMICS; TREND STUDY; TUMOR INVASION; TUMOR VOLUME; UNITED STATES; VERY ELDERLY; CANCER REGISTRY; HEALTH CARE DISPARITY; INCIDENCE; NEOPLASMS; PATHOLOGY; REGISTER;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; REGISTRIES; SEER PROGRAM; SOCIOECONOMIC FACTORS;

EID: 85014114202     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-017-0874-2     Document Type: Article

References (37)

1. Ryerson AB, Eheman CR, Altekruse SF, Ward JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM, Anderson RN, Ma J, Ly KN, Cronin KA, Penberthy L, Kohler BA (2016) Annual report to the nation on the status of cancer, 1975–2012, featuring the increasing incidence of liver cancer. Cancer 122(9):1312–1337. doi:10.1002/cncr.29936
2. Louwman WJ, Vulto JC, Verhoeven RH, Nieuwenhuijzen GA, Coebergh JW, Voogd AC (2007) Clinical epidemiology of breast cancer in the elderly. Eur J Cancer 43(15):2242–2252. doi:10.1016/j.ejca.2007.08.005
3. Bradley CJ, Clement JP, Lin C (2008) Absence of cancer diagnosis and treatment in elderly Medicaid-insured nursing home residents. J Natl Cancer Inst 100(1):21–31. doi:10.1093/jnci/djm271
4. O’Malley CD, Shema SJ, Clarke LS, Clarke CA, Perkins CI (2006) Medicaid status and stage at diagnosis of cervical cancer. Am J Public Health 96(12):2179–2185. doi:10.2105/AJPH.2005.072553
5. Chan JK, Kapp DS, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Leiserowitz GS, Cress RD, O’Malley C (2007) Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol 109(6):1342–1350. doi:10.1097/01.AOG.0000265207.27755.28
6. Worthington JL, Koroukian SM, Cooper GS (2008) Examining the characteristics of unstaged colon and rectal cancer cases. Cancer Detect Prev 32(3):251–258. doi:10.1016/j.cdp.2008.08.006
7. Klassen AC, Curriero FC, Hong JH, Williams C, Kulldorff M, Meissner HI, Alberg A, Ensminger M (2004) The role of area-level influences on prostate cancer grade and stage at diagnosis. Prev Med 39(3):441–448. doi:10.1016/j.ypmed.2004.04.031
8. Haas JS, Earle CC, Orav JE, Brawarsky P, Neville BA, Williams DR (2008) Racial segregation and disparities in cancer stage for seniors. J Gen Intern Med 23(5):699–705. doi:10.1007/s11606-008-0545-9
9. Virnig BA, Baxter NN, Habermann EB, Feldman RD, Bradley CJ (2009) A matter of race: early-versus late-stage cancer diagnosis. Health Aff 28(1):160–168. doi:10.1377/hlthaff.28.1.160
10. Bradley CJ, Given CW, Roberts C (2003) Late stage cancers in a Medicaid-insured population. Med Care 41(6):722–728. doi:10.1097/01.MLR.0000065126.73750.D1
11. Koroukian SM, Xu F, Beaird H, Diaz M, Murray P, Rose JH (2007) Complexity of care needs and unstaged cancer in elders: a population-based study. Cancer Detect Prev 31(3):199–206. doi:10.1016/j.cdp.2007.04.002
12. Mullins CD, Onukwugha E, Bikov K, Seal B, Hussain A (2010) Health disparities in staging of SEER-medicare prostate cancer patients in the United States. Urology 76(3):566–572. doi:10.1016/j.urology.2009.10.061
13. Hsieh MC, Yu Q, Wu XC, Wohler B, Fan Y, Qiao B, Jemal A, Ajani UA (2012) Evaluating factors associated with unknown SEER Summary Stage 2000 derived from collaborative stage at central registry level. J Registry Manag 39(3):101–106
14. Gurney J, Sarfati D, Stanley J, Dennett E, Johnson C, Koea J, Simpson A, Studd R (2013) Unstaged cancer in a population-based registry: prevalence, predictors and patient prognosis. Cancer Epidemiol 37(4):498–504. doi:10.1016/j.canep.2013.03.005
15. Luo Q, Yu XQ, Cooke-Yarborough C, Smith DP, O’Connell DL (2013) Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry. Cancer Epidemiol 37(6):813–819. doi:10.1016/j.canep.2013.09.008
16. Wu XC, Yu Q, Andrews PA, Ranganath P, Qiao B, Ajani U, Wohler B, Zhang Z (2010) Comparisons of directly coded SEER Summary Stage 2000 and Collaborative Staging Derived SEER Summary Stage 2000. J Registry Manag 37(4):137–140
17. Merrill RM, Sloan A, Anderson AE, Ryker K (2011) Unstaged cancer in the United States: a population-based study. BMC Cancer 11:402. doi:10.1186/1471-2407-11-402
18. SEER*Stat software (http://www.seer.cancer.gov/seerstat) version 7.0.5. (2011)
19. Rural–Urban Continuum Code (2003). United States Department of Agriculture, Economic Research Service
20. Yost K, Perkins C, Cohen R, Morris C, Wright W (2001) Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12(8):703–711
21. Joinpoint Regression Program, Version 3.5.2 (2011). Statistical Research and Applications Branch, National Cancer Institute
22. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19(3):335–351
23. Ostenfeld EB, Froslev T, Friis S, Gandrup P, Madsen MR, Sogaard M (2012) Completeness of colon and rectal cancer staging in the Danish Cancer Registry, 2004–2009. Clin Epidemiol 4(Suppl 2):33–38
24. Hawkins RA, Hoh CK (1994) PET FDG studies in oncology. Nucl Med Biol 21(5):739–747
25. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB (1994) Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 191(2):371–377. doi:10.1148/radiology.191.2.8153308
26. Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, Detterbeck F, American College of Chest P (2007) Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132 (Suppl 3):178S–201S. doi:10.1378/chest.07-1360
27. Avril N, Schelling M, Dose J, Weber WA, Schwaiger M (1999) Utility of PET in Breast Cancer. Clin Positron Imaging 2(5):261–271
28. Smith IC, Ogston KN, Whitford P, Smith FW, Sharp P, Norton M, Miller ID, Ah-See AK, Heys SD, Jibril JA, Eremin O (1998) Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-d-glucose. Ann Surg 228(2):220–227
29. Utech CI, Young CS, Winter PF (1996) Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry. Eur J Nucl Med 23(12):1588–1593
30. Hillner BE, Siegel BA, Shields AF, Liu D, Gareen IF, Hunt E, Coleman RE (2008) Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry. J Nucl Med 49(12):1928–1935. doi:10.2967/jnumed.108.056713
31. Ademuyiwa FO, Edge SB, Erwin DO, Orom H, Ambrosone CB, Underwood W 3rd (2011) Breast cancer racial disparities: unanswered questions. Cancer Res 71(3):640–644. doi:10.1158/0008-5472.CAN-10-3021
32. Soneji S, Armstrong K, Asch DA (2012) Socioeconomic and physician supply determinants of racial disparities in colorectal cancer screening. J Oncol Pract 8(5):e125–e134. doi:10.1200/JOP.2011.000511
33. Adler SR, Fosket JR, Kagawa-Singer M, McGraw SA, Wong-Kim E, Gold E, Sternfeld B (2000) Conceptualizing menopause and midlife: Chinese American and Chinese women in the U.S. Maturitas 35(1):11–23
34. Schiphorst AH, Verweij NM, Pronk A, Hamaker ME (2014) Age-related guideline adherence and outcome in low rectal cancer. Dis Colon Rectum 57(8):967–975. doi:10.1097/dcr.0000000000000145
35. Jorgensen TL, Teiblum S, Paludan M, Poulsen LO, Jorgensen AY, Bruun KH, Hallas J, Herrstedt J (2012) Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients. Gynecol Oncol 127(2):367–374. doi:10.1016/j.ygyno.2012.07.001
36. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M (2003) Trends in breast cancer by race and ethnicity. CA 53(6):342–355
37. Shi L, Lebrun LA, Zhu J, Tsai J (2011) Cancer screening among racial/ethnic and insurance groups in the United States: a comparison of disparities in 2000 and 2008. J Health Care Poor Underserved 22(3):945–961. doi:10.1353/hpu.2011.0079